NGM BIOPHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Ngm Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$27.7M, a 24.1% increase year-over-year.
  • Ngm Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$142M, a 12.5% increase year-over-year.
  • Ngm Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$142M, a 12.5% increase from 2022.
  • Ngm Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$163M, a 35.2% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$120M, a 17.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$142M +$20.3M +12.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$163M -$42.3M -35.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$120M -$17.8M -17.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 -$102M -$59.7M -139% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$42.8M -$42.3M -8581% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$493K +$13.7M +96.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 -$14.2M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.